Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Cardiology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
In collaboration with the Office of Diversity and Inclusion, student groups organized the medical school’s first Diversity and Inclusion Week, which explored the importance of diversity, inclusion and representation in medicine and society.
Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.
Several forms of hypertension are associated with higher risk of cardiovascular disease events, even in young adults, according to a recent study.
Targeting oxidative stress with a genetic therapy reduced atrial fibrillation in animal models of disease, making this a promising future treatment, according to a study published in Circulation.
At Northwestern Medicine, various COVID-19 antibody testing efforts have been underway since the beginning of the pandemic.
Deaths due to heart failure and hypertensive heart disease are increasing in the U.S. — particularly in Black women and men — despite medical and surgical advances in heart disease management, according to a new Northwestern Medicine study.
In recognition of their track record of excellence and achievement, three Feinberg faculty members have been promoted to the position of assistant dean of medical education.
Genetic mutations in desmoplakin cause left ventricular cardiomyopathy, rather than right ventricular cardiomyopathy as previously believed, according to a recent study.
Medical schools can help combat discrimination by creating safe spaces for underrepresented minority (URM) medical students, according to Quentin Youmans, ’15 MD, who founded the STRIVE program which connects URM medical students at Feinberg with URM resident mentors.
To help support and develop the next generation of physician-scientists, Feinberg has established the Thomas Starzl Academy, and named Elizabeth M. McNally, MD, PhD, its inaugural director.
According to several recent editorials published by Feinberg faculty, there are large and complex issues to grapple with, from COVID-19’s devastating impact on African-Americans to maintaining critical care standards in the face of an unprecedented pandemic.
Coronary artery calcium levels may help clinicians better identify patients with a higher risk of atherosclerotic cardiovascular disease who will benefit from taking aspirin to prevent a heart attack.
In the newly formed Center for Arrhythmia Research, teams of interdisciplinary clinicians and scientists will work together to discover both the underlying molecular causes of arrhythmias and new standards of care for their treatment.
There are variety of ways improve care delivery, interpret new information, and maintain clinical trials and experiments in the face of the COVID-19 pandemic, according to recent editorials published by Feinberg faculty.
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
A special COVID-19 testing team has been put in place at Northwestern, with the goal of at least quadrupling the number of tests processed at Northwestern Medicine hospitals — from about 90 per day to more than 350 per day — and in the process, greatly reducing test result turnaround times.
Northwestern’s Alpha Omega Alpha honor society chapter inducted 35 new members last week, including Feinberg students, residents, fellows, faculty and alumni.
Virginia Bishop, MD, MPH, assistant professor of Preventive Medicine in the Division of Public Health Practice, was a respected colleague, educator and advocate for diversity, inclusion and equity in healthcare and medical education.
Norrina Allen, PhD, is the new director of the Center for Epidemiology and Population Health.
A new study has linked the consumption of red and processed meat with a higher risk of heart disease and death.
These images illustrate the physical reality Northwestern scientists work within, striving to uncover the mysteries of biology, chemistry and medicine.
Feinberg has had an exceptional year of scientific inquiry, ranging from examining the most basic systems that make our bodies tick to developing breakthrough therapies and treatment strategies.
Feinberg’s new Institute for Global Health hosted its inaugural Global Health Day symposium, a day-long event that featured presentations from each of the institute’s constituent Centers, a poster session, several panels and keynote speakers.
Measuring atrial fibrillation through implanted devices like pacemakers can identify patients at risk for stroke, according to a recent study.
A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
This article was originally published in the Breakthroughs Newsletter. Find more stories like this, as well as the Breakthroughs Podcast, on the Breakthroughs homepage Cardiovascular health isn’t just about the heart, or about the thousands of veins, arteries, and capillaries that provide oxygen and other nutrients to every corner of the body. According to Clyde Yancy, MD, [...]
A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.
Genetic modifier protein Annexin A6 accelerates acute and chronic muscle injury repair by more than 50 percent.
Feinberg faculty and students celebrated the ninth annual Medical Education Day at the Robert H. Lurie Medical Research Center with sessions, lectures and workshops that examined the future of medical education.
Total deaths from heart disease, stroke, diabetes and hypertension have been increasing since 2011, according to a new Northwestern Medicine study.